title: Spontaneous recovery of bone mass after cure of endogenous hypercortisolism.
abstract: Patients with Cushing's syndrome (CS) develop osteopenia-osteoporosis. The present study evaluates the recovery of bone mass within 2 years after remission of hypercortisolism and in long term follow up, an issue rarely addressed. Twenty patients (6M, 14F, 3 post-menopausal, 15-64 years old), 15 with Cushing's disease, 2 with ectopic ACTH syndrome, 3 with ACTH-independent CS were studied. BMD, T and Z scores at lumbar spine and proximal femur were assessed by dual-energy X-ray absorptiometry before and 7-33 months after treatment of hypercortisolism. Five patients were treated with bisphosphonates. Four patients had hypogonadism and 4 GH-deficiency. At baseline all patients showed osteopenia/osteoporosis and the spine appeared more damaged than the femur; femur BMD was positively related with body mass index (BMI). No correlations were observed between spine and femur bone parameters and duration of disease or severity of hypercortisolism. Bone parameters did not differ in patients with or without GH or other pituitary deficiencies. After cure of hypercortisolism a significant improvement in spine BMD, Z and T scores and in femur Z and T scores was observed with normalization in 3 patients; there was no significant difference in percent improvement between femur and spine. The increase in bone parameters at spine and femur was independent from values at baseline. The percent increase in spine T and Z scores was positively related with time elapsed since cure. Bisphosphonates did not influence the recovery of bone mineralization. In long term follow up, after a median period of 7 years a further improvement in bone density was observed in 100% of patients at spine and in 9/11 at femur, although 8/11 patients still had femoral and/or vertebral T score in the range of osteopenia/osteoporosis. Spontaneous improvement of osteoporosis after cure of hypercortisolism occurs both at spine and femur, is independent from basal conditions and not affected by bisphosphonates. The improvement at spine depends on time since cure.
authors.affiliation: Endocrine Unit, Niguarda Ca'Granda Hospital, Piazza Ospedale Maggiore 3, 20162, Milan, Italy.
authors.forename: Maria Elena
authors.initials: ME
authors.lastname: Randazzo
authors.forename: Erika
authors.initials: E
authors.lastname: Grossrubatscher
authors.forename: Paolo
authors.initials: P
authors.lastname: Dalino Ciaramella
authors.forename: Angelo
authors.initials: A
authors.lastname: Vanzulli
authors.forename: Paola
authors.initials: P
authors.lastname: Loli
mesh_terms: D015502:Absorptiometry, Photon; D000293:Adolescent; D000328:Adult; D015992:Body Mass Index; D001851:Bone Diseases, Metabolic / Q000378:metabolism; D001842:Bone and Bones / Q000378:metabolism* / Q000473:pathology*; D003480:Cushing Syndrome / Q000097:blood / Q000378:metabolism / Q000601:surgery* / Q000652:urine; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010024:Osteoporosis / Q000378:metabolism; D047748:Pituitary ACTH Hypersecretion / Q000097:blood / Q000378:metabolism / Q000601:surgery* / Q000652:urine; D011446:Prospective Studies; D011863:Radioimmunoassay; D055815:Young Adult